Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 919

1.
2.

Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.

Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD.

Hum Pathol. 2001 Nov;32(11):1157-65.

PMID:
11727253
3.

Immunohistological study of cell cycle-related factors, oncogene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagus.

Fujii T, Nakagawa S, Hanzawa M, Sueyoshi S, Fujita H, Shirouzu K, Yamana H.

Oncol Rep. 2003 Mar-Apr;10(2):427-31.

PMID:
12579284
4.
6.

Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.

Burjonrappa SC, Reddimasu S, Nawaz Z, Gao X, Sharma P, Loggie B.

Indian J Cancer. 2007 Jan-Mar;44(1):1-5.

7.

Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.

Vallböhmer D, Peters JH, Oh D, Kuramochi H, Shimizu D, Demeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg P.

Surgery. 2005 Oct;138(4):701-6; discussion 706-7.

PMID:
16269299
8.
9.

Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

Lord RV, Brabender J, Wickramasinghe K, DeMeester SR, Holscher A, Schneider PM, Danenberg PV, DeMeester TR.

Surgery. 2005 Nov;138(5):924-31.

PMID:
16291394
10.

Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.

Hong MK, Laskin WB, Herman BE, Johnston MH, Vargo JJ, Steinberg SM, Allegra CJ, Johnston PG.

Cancer. 1995 Jan 15;75(2):423-9.

11.

Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.

Brabender J, Lord RV, Wickramasinghe K, Metzger R, Schneider PM, Park JM, Hölscher AH, DeMeester TR, Danenberg KD, Danenberg PV.

J Gastrointest Surg. 2002 May-Jun;6(3):359-67.

PMID:
12022988
12.

Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.

Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson JD.

Histopathology. 1999 Dec;35(6):517-24.

PMID:
10583575
13.

Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.

Glickman JN, Blount PL, Sanchez CA, Cowan DS, Wongsurawat VJ, Reid BJ, Odze RD.

Hum Pathol. 2006 Oct;37(10):1304-15. Epub 2006 Jul 20.

PMID:
16949933
14.

Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.

Abraham SC, Wang H, Wang KK, Wu TT.

Am J Surg Pathol. 2008 Jul;32(7):1068-74. doi: 10.1097/PAS.0b013e318160c579.

PMID:
18496141
15.

COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.

Villanacci V, Rossi E, Zambelli C, Galletti A, Cestari R, Missale G, Casa DD, Bassotti G.

Dig Liver Dis. 2007 Apr;39(4):305-11. Epub 2007 Feb 16.

PMID:
17307036
16.

Increased p53 expression in the malignant transformation of Barrett's esophagus is accompanied by an upward shift of the proliferative compartment.

Hritz I, Gyorffy H, Molnar B, Lakatos G, Sipos F, Pregun I, Juhasz M, Pronai L, Schaff Z, Tulassay Z, Herszenyi L.

Pathol Oncol Res. 2009 Jun;15(2):183-92. doi: 10.1007/s12253-008-9095-z. Epub 2008 Aug 28.

PMID:
18752044
17.

p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.

Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.

Mod Pathol. 2001 May;14(5):397-403.

18.

Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.

Washington K, Chiappori A, Hamilton K, Shyr Y, Blanke C, Johnson D, Sawyers J, Beauchamp D.

Mod Pathol. 1998 Sep;11(9):805-13.

PMID:
9758359
19.

DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.

Itakura Y, Sasano F, Date F, Kato K, Sekine H, Mori S, Nagura H.

Anticancer Res. 1996 Jan-Feb;16(1):201-8.

PMID:
8615609
20.

Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study.

Mendes de Almeida JC, Chaves P, Pereira AD, Altorki NK.

Ann Surg. 1997 Dec;226(6):725-33; discussion 733-5.

Items per page

Supplemental Content

Write to the Help Desk